|
1
|
Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development.
|
J Steroid Biochem Mol Biol
|
2004
|
2.19
|
|
2
|
Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer.
|
Cancer Res
|
2005
|
1.56
|
|
3
|
Identification of PDE4D as a proliferation promoting factor in prostate cancer using a Sleeping Beauty transposon-based somatic mutagenesis screen.
|
Cancer Res
|
2009
|
1.22
|
|
4
|
Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer.
|
Annu Rev Physiol
|
2007
|
1.17
|
|
5
|
Branching morphogenesis in the prostate gland and seminal vesicles.
|
Differentiation
|
2006
|
1.10
|
|
6
|
Testosterone and 17β-estradiol induce glandular prostatic growth, bladder outlet obstruction, and voiding dysfunction in male mice.
|
Endocrinology
|
2012
|
1.07
|
|
7
|
Fibroblast growth factor receptor signaling through MEK-ERK is required for prostate bud induction.
|
Differentiation
|
2007
|
1.01
|
|
8
|
Secreted frizzled related protein 1 is a paracrine modulator of epithelial branching morphogenesis, proliferation, and secretory gene expression in the prostate.
|
Dev Biol
|
2008
|
0.98
|
|
9
|
Wnt inhibitory factor 1 (Wif1) is regulated by androgens and enhances androgen-dependent prostate development.
|
Endocrinology
|
2012
|
0.96
|
|
10
|
Markers of prostate region-specific epithelial identity define anatomical locations in the mouse prostate that are molecularly similar to human prostate cancers.
|
Differentiation
|
2007
|
0.89
|
|
11
|
Sulfatase 1 is an inhibitor of ductal morphogenesis with sexually dimorphic expression in the urogenital sinus.
|
Endocrinology
|
2010
|
0.86
|
|
12
|
Dominant negative Bmp5 mutation reveals key role of BMPs in skeletal response to mechanical stimulation.
|
BMC Dev Biol
|
2008
|
0.86
|
|
13
|
Distinct expression patterns of Sulf1 and Hs6st1 spatially regulate heparan sulfate sulfation during prostate development.
|
Dev Dyn
|
2012
|
0.84
|
|
14
|
The mouse seminal vesicle shape mutation is allelic with Fgfr2.
|
Development
|
2007
|
0.83
|
|
15
|
Prostate development and pathogenesis.
|
Differentiation
|
2008
|
0.80
|
|
16
|
Recent advances in prostate development and links to prostatic diseases.
|
Wiley Interdiscip Rev Syst Biol Med
|
2013
|
0.79
|
|
17
|
A novel method for somatic transgenesis of the mouse prostate using the Sleeping Beauty transposon system.
|
Prostate
|
2014
|
0.75
|